EXEL: the balance sheet

MyFinsight

For the year ending 2026-01-02, EXEL has $2,844,423K in assets. $683,104K in debts. $482,488K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
355.80%
Quick Ratio
350.46%
Cash Ratio
118.94%
Debt to Asset Ratio
24.02%
Unit: Thousand (K) dollars
Assets Breakdown
Non-current marketable securitie...
Marketable securities
Cash and cash equivalents
Others
Liabilities Breakdown
Additional paid-in-capital
Non-current operating lease liab...
Other current liabilities
Others

Balance Sheets	2026-01-02	2025-01-03	2023-12-29	2022-12-30
Cash and cash equivalents	482,488	217,374	262,994	501,195
Short-term investments	-	-	732,308	807,273
Marketable securities	576,603	893,902	-	-
Trade receivables, net	286,916	265,437	237,407	214,784
Inventory	21,686	22,388	17,323	33,299
Prepaid expenses and other current assets	75,596	68,478	67,926	62,211
Total current assets	1,443,289	1,467,579	1,317,958	1,618,762
Non-current marketable securities	603,603	637,291	-	-
Property and equipment, net	98,960	119,391	128,731	110,624
Long-term investments	-	-	728,717	756,731
Deferred tax assets, net	292,582	420,027	361,145	231,110
Goodwill	63,684	63,684	63,684	63,684
Right-of-use assets and other	-	-	342,122	290,578
Right-of-use assets and other non-current assets	342,305	239,718	-	-
Total assets	2,844,423	2,947,690	2,942,357	3,071,489

Accounts payable	29,623	38,191	33,768	32,667
Accrued compensation and benefits	102,218	109,830	93,325	77,158
Accrued clinical trial liabilities	65,742	57,976	71,615	65,072
Rebates and fees due to customers	59,896	62,376	59,619	50,350
Accrued collaboration liabilities	22,783	40,384	27,533	20,188
Other current liabilities	125,382	95,012	108,417	78,924
Total current liabilities	405,644	403,769	394,277	324,359
Non-current operating lease liabilities	173,038	190,823	189,944	190,170
Long-term portion of deferred revenue	-	-	-	6,582
Other non-current liabilities	104,422	108,895	94,224	61,951
Total liabilities	683,104	703,487	678,445	583,062
Common stock, 0.001 par value 400,000 shares authorized issued and outstanding 262,483 and 281,732 at december31, 2025 and 2024, respectively	262	282	303	324
Additional paid-in-capital	2,234,411	2,343,915	2,440,710	2,536,849
Accumulated other comprehensive income (loss)	3,476	-1,347	-3,750	-14,521
Accumulated deficit	-76,830	-98,647	-173,351	-34,225
Total stockholders equity	2,161,319	2,244,203	2,263,912	2,488,427
Total liabilities and stockholders equity	2,844,423	2,947,690	2,942,357	3,071,489

Unit: Thousand (K) dollars (except for numbers of shares and EPS).

MyFinsight

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets